Question 1

How many shares of REGN does Candriam S.C.A. own?

Accepted Answer

As of 2026-Q1, Candriam S.C.A. holds 186,388 shares of REGN (REGENERON PHARMACEUTICALS).

Question 2

What is Candriam S.C.A.'s REGN position worth?

Accepted Answer

As of 2026-Q1, Candriam S.C.A.'s REGN position is worth $144M.

Question 3

Is Candriam S.C.A. buying or selling REGN?

Accepted Answer

In 2026-Q1, Candriam S.C.A. decreased their REGN position (-9.2% change in shares).

Question 4

When did Candriam S.C.A. first buy REGN?

Accepted Answer

Based on available 13F filings, Candriam S.C.A. first reported a position in REGN in 2024-Q2. They have held the position across 29 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Decreased	186,388	-9.2%	$144M	0.7%	$766.66	0
2025-Q4	Increased	205,332	+21.1%	$158.5M	0.8%	$773.94	51
2025-Q3	Increased	169,495	+19.2%	$95.3M	0.5%	$560.05	42
2025-Q2	Decreased	142,208	-33.8%	$74.7M	0.4%	$519.56	0
2025-Q1	Decreased	214,941	-17.8%	$136.3M	0.9%	$634.66	0
2024-Q4	Increased	261,498	+3.5%	$186.3M	1.1%	$698.71	50
2024-Q3	Increased	252,525	+25.8%	$265.5M	1.5%	$1,036.94	60
2024-Q2	Decreased	200,708	-7.8%	$210.9M	1.3%	$1,045.23	0

REGNShowing 8 of 29 quarters

REGN
Showing 8 of 29 quarters